Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
出版年份 2019 全文链接
标题
Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
作者
关键词
-
出版物
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-04
DOI
10.1007/s40261-019-00793-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
- (2018) Carlos R Camara-Lemarroy et al. BRAIN
- Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis
- (2018) Majid Ghareghani et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?
- (2018) Christiane Graetz et al. Expert Review of Neurotherapeutics
- Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
- (2018) Graham Campbell et al. FEBS LETTERS
- Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity
- (2018) Ting Long et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?
- (2018) Christiane Graetz et al. Expert Review of Neurotherapeutics
- Melatonin pharmacokinetics after transdermal administration changes according to the time of the day
- (2017) Ana Flo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
- (2017) Yang Li et al. FEBS Journal
- Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis
- (2017) Majid Ghareghani et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients
- (2017) Nuria Álvarez-Sánchez et al. JOURNAL OF PINEAL RESEARCH
- Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
- (2017) Monika Adamczyk-Sowa et al. Oxidative Medicine and Cellular Longevity
- Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
- (2017) Patrick Peschl et al. Frontiers in Immunology
- Melatonin as an Antioxidant for Stroke Neuroprotection
- (2016) Nate Watson et al. CELL TRANSPLANTATION
- Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression
- (2016) Majid Ghareghani et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
- (2016) Judith Bellapart et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis
- (2016) Shyi-Jou Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis
- (2016) Jie Wen et al. Journal of Neuroimmune Pharmacology
- Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes
- (2016) Solaleh Emamgholipour et al. LIFE SCIENCES
- Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
- (2016) Josiel Mileno Mack et al. Oxidative Medicine and Cellular Longevity
- Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance
- (2015) Nuria Álvarez-Sánchez et al. BRAIN BEHAVIOR AND IMMUNITY
- Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
- (2015) Mauricio F. Farez et al. CELL
- The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
- (2015) Wouter Kamphuis et al. CNS & Neurological Disorders-Drug Targets
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination
- (2015) Gelareh Vakilzadeh et al. MOLECULAR NEUROBIOLOGY
- Why does multiple sclerosis only affect human primates?
- (2015) Bert A ‘t Hart Multiple Sclerosis Journal
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- Why does multiple sclerosis only affect human primates?
- (2015) Bert A ‘t Hart Multiple Sclerosis Journal
- The role of melatonin in diabetes: therapeutic implications
- (2015) Shweta Sharma et al. Archives of Endocrinology Metabolism
- Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
- (2015) Roberta Mancuso et al. PLoS One
- Role of the Blood–Brain Barrier in Multiple Sclerosis
- (2014) Genaro Gabriel Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions
- (2014) Sahil Gupta et al. CNS DRUGS
- Multiple Sclerosis: Current Knowledge and Future Outlook
- (2014) Christian P. Kamm et al. EUROPEAN NEUROLOGY
- Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies
- (2014) Gayathri Sundaram et al. Journal of Neuroinflammation
- N-Acetyl-Serotonin Offers Neuroprotection through Inhibiting Mitochondrial Death Pathways and Autophagic Activation in Experimental Models of Ischemic Injury
- (2014) H. Zhou et al. JOURNAL OF NEUROSCIENCE
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis
- (2014) Iraj Ragerdi Kashani et al. EXPERIMENTAL BRAIN RESEARCH
- Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course
- (2013) Elżbieta Miller et al. JOURNAL OF NEUROIMMUNOLOGY
- JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury
- (2013) Yang Yang et al. JOURNAL OF PINEAL RESEARCH
- Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients
- (2012) Renuka Natarajan et al. JOURNAL OF NEUROIMMUNOLOGY
- Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes
- (2012) Seithikurippu R. Pandi-Perumal et al. NEUROTOXICITY RESEARCH
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage
- (2011) Trevor W. Stone et al. JOURNAL OF NEURAL TRANSMISSION
- Interleukin-6 autocrine signaling mediates melatonin MT1/2receptor-induced STAT3 Tyr705phosphorylation
- (2011) Winnie W. I. Lau et al. JOURNAL OF PINEAL RESEARCH
- Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
- (2011) Lena Melamud et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
- (2010) Daniel P. Cardinali et al. Current Neuropharmacology
- Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
- (2010) G. Anderson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy
- (2010) Mariam Chahbouni et al. JOURNAL OF PINEAL RESEARCH
- Oligodendrocytes: biology and pathology
- (2009) Monika Bradl et al. ACTA NEUROPATHOLOGICA
- The cuprizone model for demyelination
- (2008) Ø. Torkildsen et al. ACTA NEUROLOGICA SCANDINAVICA
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials
- (2008) Shantha MW Rajaratnam et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started